Advances in Cancer Research, Volume 85

1st Edition

Editors: George Vande Woude George Klein
Hardcover ISBN: 9780120066858
eBook ISBN: 9780080488219
Imprint: Academic Press
Published Date: 30th September 2002
Page Count: 251
161.00 + applicable tax
137.00 + applicable tax
110.00 + applicable tax
185.00 + applicable tax
Unavailable
Compatible Not compatible
VitalSource PC, Mac, iPhone & iPad Amazon Kindle eReader
ePub & PDF Apple & PC desktop. Mobile devices (Apple & Android) Amazon Kindle eReader
Mobi Amazon Kindle eReader Anything else

Institutional Access


Table of Contents

The Von Hippel-Lindau Tumor Suppressor Complex and Regulation of Hypoxia-Inducible Transcription. Retinoblastoma Tumor Suppressor and Genome Stability. The Abl Family Kinases: Mechanisms of Regulation and Signaling. Cellular Immunity to the Her-2/neu Proto-oncogene. A New Challenge for Successful Immunotherapy by Tumors That Are Resistant to Apoptosis: Two Complementary Signals to Overcome Cross-Resistance. Cell Volume and Ion Changes During Apoptotic Cell Death. Mitochondria and Apoptosis: New Therapeutic Targets.

Readership

Researchers and students in the basic and clinical science of cancer biology and oncology, genetics, immunology, pharmacology, cell and molecular biology.


Details

No. of pages:
251
Language:
English
Copyright:
© Academic Press 2002
Published:
Imprint:
Academic Press
eBook ISBN:
9780080488219
Hardcover ISBN:
9780120066858

Reviews

@from:PRAISE FOR THE SERIES @qu:"This classic and essential series presents critical overviews on select aspects of both cancer research and the basic underlying sciences." @source:—AMERICAN SCIENTIST @qu:"Excellent, highly informative, in-depth reviews...expertly written, up-to-date, and well-referenced." @source:—JOURNAL OF MEDICINAL CHEMISTRY @qu:"This is a series that has a long tradition of excellence in the field of cancer biology." @source:—DOODY'S PUBLISHING REVIEWS


About the Editors

George Vande Woude Editor

Affiliations and Expertise

Director, Van Andel Research Institute, Grand Rapids, MI, USA NCI-Frederick Cancer Research Facility Frederick, Maryland ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland

George Klein Editor

Affiliations and Expertise

Karolinska Insitutet, Stockholm, Sweden